• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Elluminex and Its Potential in the DeFi Era on the TON Blockchain

user avatar

by Giorgi Kostiuk

10 months ago


In 2024, Fantom (FTM) and Sui (SUI) captured attention with significant returns. However, Elluminex (ELX) is expected to outperform them by unlocking the potential of the TON blockchain.

How Elluminex Is Pioneering DeFi On TON

TON, the fastest-growing blockchain in the Layer 1 space, leverages Telegram's user base, but lacks a unified DeFi solution. Elluminex aims to provide this with an ecosystem solving inefficiencies in existing protocols through its cross-chain bridge, integrating major blockchains. At its core is the $ELX token, enabling governance and staking.

Challenges for Fantom: What's Next?

After a summer slump, Fantom (FTM) saw price increases but recently declined below $1.20. Trading volumes are up as the new Layer 1 named Sonic is live, offering fast transaction processing and an upcoming airdrop.

Sui Continues Its Success

Sui (SUI) has been growing steadily, reaching new highs. Recently, Sui partnered with SatLayer to integrate Bitcoin's security and liquidity into its ecosystem, enhancing DeFi capabilities.

Elluminex promises significant changes for DeFi on the TON platform, offering unique solutions for users and potential future growth.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Crypto Derivatives Industry Faces Structural Critique

chest

A fresh bout of soulsearching has gripped the crypto derivatives industry as leading market participants argue that the market's structure is fundamentally flawed.

user avatarDavid Robinson

Bitcoin Hyper Revolutionizes Smart Contracts on Bitcoin

chest

Bitcoin Hyper aims to address Bitcoin's limitations by introducing a high-speed execution layer for smart contracts.

user avatarAndrew Smith

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.